1. Home
  2. AUPH vs CWH Comparison

AUPH vs CWH Comparison

Compare AUPH & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • CWH
  • Stock Information
  • Founded
  • AUPH 1993
  • CWH 1966
  • Country
  • AUPH Canada
  • CWH United States
  • Employees
  • AUPH N/A
  • CWH N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • CWH Retail-Auto Dealers and Gas Stations
  • Sector
  • AUPH Health Care
  • CWH Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • CWH Nasdaq
  • Market Cap
  • AUPH 1.1B
  • CWH 1.2B
  • IPO Year
  • AUPH 1999
  • CWH 2016
  • Fundamental
  • Price
  • AUPH $8.86
  • CWH $18.30
  • Analyst Decision
  • AUPH Strong Buy
  • CWH Strong Buy
  • Analyst Count
  • AUPH 2
  • CWH 9
  • Target Price
  • AUPH $11.50
  • CWH $22.00
  • AVG Volume (30 Days)
  • AUPH 1.9M
  • CWH 2.6M
  • Earning Date
  • AUPH 07-31-2025
  • CWH 07-30-2025
  • Dividend Yield
  • AUPH N/A
  • CWH 2.71%
  • EPS Growth
  • AUPH N/A
  • CWH N/A
  • EPS
  • AUPH 0.27
  • CWH N/A
  • Revenue
  • AUPH $247,295,000.00
  • CWH $6,149,481,000.00
  • Revenue This Year
  • AUPH $12.15
  • CWH $3.87
  • Revenue Next Year
  • AUPH $18.31
  • CWH $7.62
  • P/E Ratio
  • AUPH $33.04
  • CWH N/A
  • Revenue Growth
  • AUPH 29.20
  • CWH 0.75
  • 52 Week Low
  • AUPH $5.20
  • CWH $11.17
  • 52 Week High
  • AUPH $10.67
  • CWH $25.97
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 64.10
  • CWH 52.79
  • Support Level
  • AUPH $7.36
  • CWH $17.74
  • Resistance Level
  • AUPH $9.10
  • CWH $19.24
  • Average True Range (ATR)
  • AUPH 0.44
  • CWH 0.81
  • MACD
  • AUPH 0.10
  • CWH -0.06
  • Stochastic Oscillator
  • AUPH 89.53
  • CWH 51.61

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is retailer of RVs and related products and services. The Company has the two reportable segments: Good Sam Services and Plans segment includes sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories. RV and Outdoor Retail segment includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, sale of outdoor products, equipment, gear and supplies; business to business distribution of RV furniture, etc.

Share on Social Networks: